Appili Therapeutics Reports Fiscal Year 2023 Financial and Operational Results
Executed US$7.3M initial contract with U.S. Air Force Academy for ATI-1701 Upcoming PDUFA date of September 23, 2023 for ATI-1501
United States Don Cilla Contract Drug Manufacturing Organization Appili Therapeutics Inc Trademark Office International Accounting Standard Board
Source: marketscreener.com